2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action

Autor: Rawal, Ravindra K., Singh, Uma S., Chavre, Satish N, Wang, Jianing, Sugiyama, Masaya, Hung, Wai, Govindarajan, Rajgopal, Korba, Brent, Tanaka, Yasuhito, Chu, Chung K.
Zdroj: In Bioorganic & Medicinal Chemistry Letters 15 January 2013 23(2):503-506
Databáze: ScienceDirect
Externí odkaz: